Ingredient guide · Ingredient reference

Kaempferol in high-fat-fed mice: promising markers are not a human trial

The experiment examined fat depots, metabolic measures and inflammation in thirty male mice.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

The study and its comparison

Thirty male mice were divided among normal diet, high-fat diet and high-fat diet containing kaempferol for sixteen weeks. The paper also included experiments in cultured fat-cell precursors. [1]

Compared with high-fat feeding alone, kaempferol reduced selected fat depots and improved several lipid, liver and inflammatory measurements. The study used a defined experimental diet rather than an ordinary food comparison. [1]

What the finding establishes

The results do not establish weight loss or diabetes prevention in people. Male mice and cultured cells cannot define a safe or effective human supplement dose. Authors declared no potential conflicts; complete funding was not established from the retrieved record. Multiple biochemical findings should not be presented as multiple proven clinical benefits. [1]

A hypothetical distinction

Imagine several markers improve in one animal experiment. They remain one preclinical evidence setting, not several patient trials.

Interpretation checklist — Kaempferol in high-fat-fed mice
DetailInterpretation
Measured outcomeKeep the endpoint specific
Study preparationNot every retail product
Remaining uncertaintyNot resolved by a mechanism
Kaempferol in high-fat-fed mice: promising markers are not a human trial — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Kaempferol ameliorates metabolic syndrome by inhibiting inflammation and oxidative stress in high-fat diet-induced obese mice.
    Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.